APTO Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 19:45):

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States...

Stats
Tagesvolumen	18 978.00
Durchschnittsvolumen	80 112.00
Marktkapitalisierung	19.33M
EPS	$0 ( 2024-03-26 )
Nächstes Ertragsdatum	( $-0.820 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.160
ATR14	$0.0140 (1.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-05	Payne Fletcher	Buy	55 000	Employee Stock Option (Right to Buy)
2024-02-05	Bejar Rafael	Buy	35 000	Employee Stock Option (Right to Buy)
2024-02-05	Ledru Philippe	Buy	11 000	Employee Stock Option (Right to Buy)
2024-02-05	Rice William G.	Buy	70 000	Employee Stock Option (Right to Buy)
2024-02-05	Seizinger Bernd R.	Buy	3 333	Director Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 94 transactions
Buy: 9 955 760 \| Sell: 550 471

Volumen Korrelation

Lang: 0.03 (neutral)

Kurz: 0.75 (moderate)

Signal:(55.791) Neutral

Aptose Biosciences Inc Korrelation

10 Am meisten positiv korreliert
HCTI	0.957
RMRM	0.954
ATRS	0.95
LIQT	0.941
LABP	0.937
APLT	0.936
XLRN	0.925
BLU	0.914
TRKA	0.912
MNST	0.907

10 Am meisten negativ korreliert
NTGR	-0.922
EVBG	-0.921
SLAB	-0.912
TCON	-0.909
CPSI	-0.909
PI	-0.907
ENPH	-0.9
AUB	-0.898
TENB	-0.898
HONE	-0.894

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Aptose Biosciences Inc Korrelation - Währung/Rohstoff

0.30
( neutral )

0.23
( neutral )

0.00
( neutral )

0.43
( neutral )

-0.76
( moderate negative )

-0.42
( neutral )

Aptose Biosciences Inc Finanzdaten

Annual	2023
Umsatz:	$0
Bruttogewinn:	$-474 545 (0.00 %)
EPS:	$-7.72

FY	2023
Umsatz:	$0
Bruttogewinn:	$-474 545 (0.00 %)
EPS:	$-7.72

FY	2022
Umsatz:	$0
Bruttogewinn:	$-507 079 (0.00 %)
EPS:	$-6.67

FY	2021
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-0.730

Financial Reports:

No articles found.

Aptose Biosciences Inc

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.